Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Load 375 intrauterine contraceptive device
21040000280
|
Load 375 intrauterine contraceptive device | Contraceptive Devices | Appliances | No data available |
|
Locabiotal 500micrograms/dose nasal/oromucosal spray
1202030D0BBABAB
|
Locabiotal | Fusafungine | Ear, Nose and Oropharynx | No data available |
|
Loceryl 0.25% cream
1310020A0BBABAB
|
Loceryl | Amorolfine hydrochloride | Skin | No data available |
|
Lockets Medicated linctus
030902000BECIA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Locoid C cream
1304000W0BBAECA
|
Locoid | Hydrocortisone butyrate | Skin | No data available |
|
Locoid C ointment
1304000W0BBAFCB
|
Locoid | Hydrocortisone butyrate | Skin | No data available |
|
Lodotra 1mg modified-release tablets
0603020X0BDAAAE
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Lodotra 2mg modified-release tablets
0603020X0BDABAF
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Lodotra 5mg modified-release tablets
0603020X0BDACAG
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Lofensaid 25mg gastro-resistant tablets
1001010C0BRABAD
|
Lofensaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Lofensaid 50mg gastro-resistant tablets
1001010C0BRAAAE
|
Lofensaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Lofensaid Retard 100 tablets
1001010C0BRADAF
|
Lofensaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Lofensaid Retard 75 tablets
1001010C0BRACAL
|
Lofensaid | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Lofepramine 140mg/5ml oral liquid
0403010R0AAAHAH
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 23mg/5ml oral liquid
0403010R0AAAKAK
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 35mg/5ml oral liquid
0403010R0AAAMAM
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 5mg/5ml oral liquid
0403010R0AAAIAI
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofepramine 70mg/5ml oral liquid
0403010R0AAAGAG
|
Lofepramine hydrochloride | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lofexidine 200microgram tablets
0410030D0AAAAAA
|
Lofexidine hydrochloride | Lofexidine hydrochloride | Central Nervous System | No data available |
|
LoFric Cath-Kit catheter female 8Ch-18Ch
21020000936
|
LoFric Cath-Kit catheter female 8Ch-18Ch | Catheters | Appliances | No data available |
|
LoFric Cath-Kit catheter male 8Ch-18Ch
21020000935
|
LoFric Cath-Kit catheter male 8Ch-18Ch | Catheters | Appliances | No data available |
|
LoFric Cath-Kit catheter male Tiemann tip 10Ch-18Ch
21020000938
|
LoFric Cath-Kit catheter male Tiemann tip 10Ch-18Ch | Catheters | Appliances | No data available |
|
LoFric Cath-Kit catheter paediatric 6Ch-10Ch
21020000937
|
LoFric Cath-Kit catheter paediatric 6Ch-10Ch | Catheters | Appliances | No data available |
|
LoFric catheter male 8Ch-24Ch
21020000278
|
LoFric catheter male 8Ch-24Ch | Catheters | Appliances | No data available |
|
LoFric catheter male Tiemann tip 10Ch-20Ch
21020000281
|
LoFric catheter male Tiemann tip 10Ch-20Ch | Catheters | Appliances | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.